Showing results (121-130 of 170) with videos related to

Sort By:
Pageof 17
The Journal of Biological Chemistry|December 17, 2002
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cellsKlaus Podar, Yu-Tzu Tai, Craig E Cole, et al.
Blood|December 3, 2003
GW654652, the pan-inhibitor of VEGF receptors, blocks the growth and migration of multiple myeloma cells in the bone marrow microenvironmentKlaus Podar, Laurence P Catley, Yu-Tzu Tai, et al.
Blood|September 13, 2003
Identification of genes modulated in multiple myeloma using genetically identical twin samplesNikhil C Munshi, Teru Hideshima, Daniel Carrasco, et al.
Cancer Research|June 11, 2009
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myelomaJing Zhang, Martin Sattler, Giovanni Tonon, et al.
Cancer Research|April 17, 2004
Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implicationsYu-Tzu Tai, Laurence P Catley, Constantine S Mitsiades, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
Molecular sequelae of proteasome inhibition in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
British Journal of Haematology|September 16, 2009
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465Joseph M Negri, Douglas W McMillin, Jake Delmore, et al.
Cancer Research|October 3, 2003
Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signalingYu-Tzu Tai, Klaus Podar, Laurence Catley, et al.
Blood|May 5, 2005
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosisKenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, et al.
Oncogene|June 12, 2020
The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myelomaLisa J Crawford, David C Campbell, Jonathan J Morgan, et al.
Pageof 17